about
A large multi-centre European study validates high-sensitivity C-reactive protein (hsCRP) as a clinical biomarker for the diagnosis of diabetes subtypes.Circulating ghrelin level is higher in HNF1A-MODY and GCK-MODY than in polygenic forms of diabetes mellitus.1,5-Anhydroglucitol as a marker of maternal glycaemic control and predictor of neonatal birthweight in pregnancies complicated by type 1 diabetes mellitus.Increased plasma kidney injury molecule-1 suggests early progressive renal decline in non-proteinuric patients with type 1 diabetes.The first case report of sulfonylurea use in a woman with permanent neonatal diabetes mellitus due to KCNJ11 mutation during a high-risk pregnancy.Markers of early progressive renal decline in type 2 diabetes suggest different implications for etiological studies and prognostic tests development.Association of retrospective markers of glycemia and the use of continuous glucose monitoring in white adults with type 2 diabetes mellitus--a preliminary reportThe protective factors as biomarkers and targets for prevention and treatment of diabetic nephropathy: from current human evidence to future possibilities
P50
Q34205887-7256BE1C-9488-4982-8D45-C6A3200D868AQ36327109-1D0030FE-8C7D-481B-8344-ABE6BF80D075Q36660438-563D131F-0F10-408F-B258-0CECE0C796E5Q36844894-0FF97D5C-E68E-461E-AB80-5F182EAD705EQ43064177-65AFD0C5-C017-459D-8FD0-220A9AD899F3Q49344413-720599BF-64DF-4912-8AFE-C5A299482F8DQ87385804-8D7E4C26-D0FA-41AB-B3AF-FDD5CEA0A590Q90514348-9D8F48BC-EF81-4755-BC2B-211FE4112198
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
N Nowak
@en
N Nowak
@nl
type
label
N Nowak
@en
N Nowak
@nl
prefLabel
N Nowak
@en
N Nowak
@nl
P31
P496
0000-0002-1019-1395